ArticleActa neurochirurgica2026
Quantitative facial analysis using emotrics in patients undergoing vestibular schwannoma surgery.
Article in Acta neurochirurgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveFacial nerve dysfunction is a common complication after vestibular schwannoma (VS) resection. Traditional grading scales such as House-Brackmann (HB), Sunnybrook, and Fisch are subjective and prone to inter-rater variability. Emotrics, a computer vision-based tool, offers objective facial analysis, but its role in neurosurgical populations remains underexplored.
methodsPatients undergoing VS surgery were prospectively enrolled in this study. Standardized frontal facial photographs were taken preoperatively, at discharge, and at three-month follow-up. Emotrics quantified facial symmetry and movement across static, dynamic, and synkinesis domains. Composite scores were generated and compared with clinical grading scales and patient characteristics.
resultsThirty-six patients (mean age 51.2 ± 12.3 years) were included. Emotrics detected significant improvement in dynamic function (mean score: 0.41 at discharge vs. 0.56 at 3 months, p < 0.01) and synkinesis (0.62 to 0.51, p < 0.05); static symmetry remained stable. Strongest correlations with clinical grading were found at discharge and 3 months. Discharge Emotrics total scores correlated significantly with HB (r = -0.883, p < 0.001), Sunnybrook (r = 0.892, p < 0.001), and Fisch (r = 0.883, p < 0.001). At 3 months, dynamic scores remained strongly associated with HB (r = -0.799), Sunnybrook and Fisch (r = 0.790; p = 0.001). Worse Emotrics outcomes were linked to older age (62.1 vs. 48.6 years, p = 0.04) and larger tumor volume (8.2 vs. 4.5 cm
conclusionsEmotrics offers objective assessment of facial nerve function, correlates well with clinical scales, and enhances evaluation of dynamic facial recovery. Its integration may refine postoperative monitoring and guide rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.